Itvisma (onasemnogene abeparvovec-brve) is a gene therapy that the FDA has approved to treat spinal muscular atrophy (SMA) in adults, teens, and children 2 or older who have a confirmed mutation in the survival motor… Read more
Hyrnuo (sevabertinib) is a new oral medicine for adults with advanced nonsquamous non-small-cell lung cancer (NSCLC) carrying a specific genetic change known as HER2 (ERBB2) TKD activating mutations and whose cancer has either advanced locally… Read more
The FDA has approved a new combination therapy that uses two different types of anticancer medicines for treating adults with muscle-invasive bladder cancer (MIBC) who can’t receive cisplatin, a common chemotherapy drug. The approved combination… Read more
Imdelltra (tarlatamab-dlle) is a first-of-its kind targeted cancer medicine called a bispecific T-cell engager approved for treating adults with extensive-stage small-cell lung cancer (ES-SCLC) that has gotten worse on or after chemotherapy with platinum-based cancer… Read more
Redemplo (plozasiran) is a type of medicine called a small interfering RNA (siRNA) therapy approved to help lower extremely high triglyceride levels in adults with familial chylomicronemia syndrome (FCS) or ongoing chylomicronemia. This medicine works… Read more
Fasenra (benralizumab), a targeted medicine called a monoclonal antibody, binds to and reduces levels of eosinophils, a type of immune cell that can cause inflammation. This can ease symptoms in people with eosinophil-driven conditions. First… Read more
Trimbow (beclomethasone dipropionate/formoterol fumarate/glycopyrrolate), a single inhaler that contains three medicines, is now FDA-approved for maintaining asthma control in adults. About 27 million Americans have asthma, of which 30% to 50% have frequent symptoms that… Read more
Datroway (datopotamab deruxtecan-dlnk) is a prescription intravenous targeted cancer medicine called an antibody-drug conjugate (ADC). The FDA has approved it for adults with triple-negative breast cancer (TNBC) when the tumor cannot be removed with surgery… Read more
FDA Clears Once-Daily Linzess Capsule for Functional Constipation in Children Ages 2 Years and Older
Linzess (linaclotide) is a prescription once-daily oral medicine used to treat certain types of constipation, including those with no known cause and those related to irritable bowel syndrome (IBS-C). In the current approval, the FDA… Read more
Imfinzi (durvalumab) is a prescription immunotherapy medicine used to treat different types of cancer. The FDA has approved the combination of Imfinzi and Bacillus Calmette-Guérin (BCG) therapy to treat a high-risk, early form of bladder… Read more